supp.fit

Digestive Enzymes: study protocols

18 study groups say how much Digestive Enzymes participants took a day. These are the doses the studies gave. They are not a recommendation.

Digestive Enzymes: what the research found →

Dose per serving from products

144 products in our catalogue print how much Digestive Enzymes a serving holds.

Most common: 50 mg to 100 mg, 44% of 144 products.

Dose per servingProducts
500 mcg to 1 mg
11
1 mg to 2.5 mg
0
2.5 mg to 5 mg
2
5 mg to 10 mg
13
10 mg to 25 mg
8
25 mg to 50 mg
19
50 mg to 100 mg
63
100 mg to 250 mg
25
over 250 mg
3

Dose per serving from research

17 study groups in 13 studies say how much Digestive Enzymes participants took a day.

These are the doses the studies gave. They are not a recommendation.

Most common: 500 mg to 1 g, 29% of 17 study groups.

Daily doseStudy groups
25 mg to 50 mg
2
50 mg to 100 mg
1
100 mg to 250 mg
1
250 mg to 500 mg
3
500 mg to 1 g
5
1 g to 2.5 g
1
2.5 g to 5 g
1
5 g to 10 g
2
over 10 g
1

Commonly used together

1 of 18 study groups took Digestive Enzymes with something else, but nothing that 3 or more different studies gave.

18 study groups

Study
Preventive Effect of High-Dose Digestive Enzyme Management on Development of Nonalcoholic Fatty Liver Disease after Pancreaticoduodenectomy: A Randomized Controlled Clinical Trial
2020 · normal-dose digestive enzyme treatment · Patients undergoing elective pancreaticoduodenectomy
3 g1 year39
[The treatment of ENT phlogosis: seaprose S vs. nimesulide]
1993 · Seaprose S · Patients with ENT-related inflammatory conditions and patients undergoing otorhinolaryngological surgery
90 mg7 days160
Efficacy of digestive enzyme supplementation in functional dyspepsia: A monocentric, randomized, double-blind, placebo-controlled, clinical trial
2023 · multi-enzyme blend group · Adults aged 18–59 with functional dyspepsia
400 mg60 days60
Evaluation of the Safety and Efficacy of a Multienzyme Complex in Patients with Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study
2018 · MEC group · Men and women aged 18–75 with functional dyspepsia
150 mg60 days20
Lipase Supplementation before a High-Fat Meal Reduces Perceptions of Fullness in Healthy Subjects
2015 · lipase · Healthy volunteers aged 23 to 61 years, 12 male and 4 female
280 mg1 day16
Enzyme therapy for management of coeliac disease
2005 · Enzyme extract · Coeliac patients in remission challenged with gluten; age and sex not reported
900 mg2 weeks—
Preventive Effect of High-Dose Digestive Enzyme Management on Development of Nonalcoholic Fatty Liver Disease after Pancreaticoduodenectomy: A Randomized Controlled Clinical Trial
2020 · high-dose digestive enzyme treatment · Patients undergoing elective pancreaticoduodenectomy
12 g1 year41
Safety and Efficacy of N-SORB(®), a Proprietary KD120 MEC Metabolically Activated Enzyme Formulation: A Randomized, Double-Blind, Placebo-Controlled Study
2019 · N-SORB · Healthy male and female volunteers; mean age 25.8 ± 12.1 years
2 mL90 days—
Effect of probiotics on postoperative quality of gastric bypass surgeries: a prospective randomized trial
2016 · digestive enzymes group · Patients with severe obesity who had undergone gastric bypass and experienced postoperative symptomatic GI episodes; ages and sex not reported
540 mg2 weeks20
Combination of Gluten-Digesting Enzymes Improved Symptoms of Non-Celiac Gluten Sensitivity: A Randomized Single-blind, Placebo-controlled Crossover Study
2018 · enzyme mixture · Adults older than 18 with non-celiac gluten sensitivity and gluten intolerance symptoms
750 mg2 weeks—
Latiglutenase Protects the Mucosa and Attenuates Symptom Severity in Patients With Celiac Disease Exposed to a Gluten Challenge
2022 · IMGX003 · Adults aged 18–80 with treated, biopsy-confirmed celiac disease in remission, following a gluten-free diet for more than one year
1.2 g6 weeks26
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
2013 · TGD300 group · Adults with established type 2 diabetes, HbA1c 5.8–7.5% at screening, and stable diabetes medication
300 mg12 weeks23
Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
2013 · TGD900 group · Adults with established type 2 diabetes, HbA1c 5.8–7.5% at screening, and stable diabetes medication
900 mg12 weeks22
Effect of Aspergillus niger prolyl endopeptidase in patients with celiac disease on a long-term gluten-free diet
2024 · AN-PEP treatment · Adults with histologically and serologically established celiac disease who had followed a gluten-free diet for more than 2 years
975 mg4 weeks19
P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin
2009 · oral P1A recombinant beta-lactamase · healthy subjects
32.8 mg5 days—
P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin
2009 · ampicillin plus oral P1A recombinant beta-lactamase · healthy subjects
32.8 mg5 days—
Effects of pancreatic digestive enzymes, sodium bicarbonate, and a proton pump inhibitor on steatorrhoea caused by pancreatic diseases
1995 · Group II · Patients with pancreatic steatorrhoea, including patients with pancreatitis, pancreatic surgery or pancreatic cancer
9 g4 weeks—
Effects of pancreatic digestive enzymes, sodium bicarbonate, and a proton pump inhibitor on steatorrhoea caused by pancreatic diseases
1995 · Group III · Patients with pancreatic steatorrhoea, including patients with pancreatitis, pancreatic surgery or pancreatic cancer
9 g4 weeks—